FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, M.
Right arrow Articles by Gorski, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, M.
Right arrow Articles by Gorski, J. P.

The FASEB Journal, Vol 6, 2966-2976, Copyright © 1992 by The Federation of American Societies for Experimental Biology


RESEARCH COMMUNICATIONS

Bone acidic glycoprotein 75 inhibits resorption activity of isolated rat and chicken osteoclasts

M Sato, W Grasser, S Harm, C Fullenkamp and JP Gorski
Department of Bone Biology and Osteoporosis Research, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.

Matrix protein effects on the differentiated activity of osteoclasts were examined in order to understand the functional significance of bone protein interactions with osteoclasts. Bone acidic glycoprotein 75 (BAG 75) from rat calvariae inhibited the resorption of bone by isolated rat osteoclasts with IC50 = 1 nM compared to IC50 = 10 nM for chicken osteoclasts. By contrast, other phosphoproteins similarly isolated from bone were less effective in inhibiting resorption with IC50 = 100 nM osteopontin and IC50 greater than 100 nM bone sialoprotein. Likewise, RGD-containing matrix proteins vitronectin, thrombospondin, and fibronectin all displayed IC50 greater than or equal to 100 nM. Mechanistically, 10 nM BAG 75 marginally slowed, but did not block, the association of bone particles with chicken osteoclasts compared with osteopontin or control media. Pretreatment of osteoclasts with 50 nM BAG 75 had no effect on subsequent bone resorption; however, pretreatment of bone with BAG 75 before incubation with osteoclasts reduced the extent of resorption by 55%. These data suggest that a BAG 75/bone surface complex, rather than BAG 75 alone, represents the inhibitory form. Consistent with this hypothesis, direct binding studies provided no evidence of specific, high-affinity receptors on osteoclasts for BAG 75, nor was an excess of BAG 75 (100 nM) able to compete with 0.3 nM sechistatin for osteoclastic avB3-like receptors. However, BAG 75 displayed cooperative binding to tissue fragments and bone particles at concentrations greater than 10 nM, suggesting that BAG 75 self-associates into higher-order species on bone surfaces. Electron microscopy confirmed the time-dependent polymerization of BAG 75 into interconnecting filaments. These data suggest a novel, inhibitory activity for surface-bound BAG 75 on bone resorption that does not appear to involve the osteoclastic avB3-like integrin.


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
J. Yan, S. Chen, Y. Zhang, X. Li, Y. Li, X. Wu, J. Yuan, A. G. Robling, R. Karpur, R. J. Chan, et al.
Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1
Hum. Mol. Genet., April 1, 2008; 17(7): 936 - 948.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Gorski, A. Wang, D. Lovitch, D. Law, K. Powell, and R. J. Midura
Extracellular Bone Acidic Glycoprotein-75 Defines Condensed Mesenchyme Regions to be Mineralized and Localizes with Bone Sialoprotein during Intramembranous Bone Formation
J. Biol. Chem., June 11, 2004; 279(24): 25455 - 25463.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Midura, A. Wang, D. Lovitch, D. Law, K. Powell, and J. P. Gorski
Bone Acidic Glycoprotein-75 Delineates the Extracellular Sites of Future Bone Sialoprotein Accumulation and Apatite Nucleation in Osteoblastic Cultures
J. Biol. Chem., June 11, 2004; 279(24): 25464 - 25473.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Gorski, F.-T. Liu, A. Artigues, L. F. Castagna, and P. Osdoby
New Alternatively Spliced Form of Galectin-3, a Member of the beta -Galactoside-binding Animal Lectin Family, Contains a Predicted Transmembrane-spanning Domain and a Leucine Zipper Motif
J. Biol. Chem., May 17, 2002; 277(21): 18840 - 18848.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Otto, R. Chandrasekeran, C. Vermes, K. Mikecz, A. Finnegan, S. E. Rickert, J. T. Enders, and T. T. Glant
A Genome Scan Using a Novel Genetic Cross Identifies New Susceptibility Loci and Traits in a Mouse Model of Rheumatoid Arthritis
J. Immunol., November 1, 2000; 165(9): 5278 - 5286.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kitazawa, F. P. Ross, K. McHugh, and S. L. Teitelbaum
Interleukin-4 Induces Expression of the Integrin alpha(v)beta(3) via Transactivation of the beta(3) Gene
J. Biol. Chem., February 24, 1995; 270(8): 4115 - 4120.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by The Federation of American Societies for Experimental Biology.